NAV as on 2026-07-17 · Equity · Other ETFs
AUM
₹17 Cr
1Y Return
+10.7%
3Y CAGR
-
5Y CAGR
-
Expense
0.17%
Risk
Very High
1Y Return
+10.7%
3Y CAGR
-
5Y CAGR
-
Since Inception
+15.0%
AI Fund Analysis
Get AI-powered verdict, strengths, risks, and SIP recommendations for this fund.
NAV History
Drag or scroll the chart to pan through history
52-Week NAV Range
91% from 52W low
Fund Information
Fund House
DSP Mutual Fund
Category
Equity - Other ETFs
Min SIP
₹500
Min Lumpsum
₹5,000
Portfolio Composition
Asset Allocation
Market Cap Split
Fundamentals
P/E Ratio
39.02
P/B Ratio
5.30
Dividend Yield
0.63%
Price/Sale
5.63
Price/Cash Flow
29.52
Peer Comparison
| Fund | AUM (Cr) | Exp % | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| DSP Nifty Healthcare ETF | 17 | 0.17 | +10.7% | - | - |
| Nippon India Pharma Bns | 9,044 | 1.52 | +6.6% | +19.8% | +12.3% |
| ICICI Pru Pharma Healthcare Dg DirIDCW-P | 6,625 | 0.86 | +6.6% | +24.9% | +16.0% |
| SBI Healthcare Opportunities Dir IDCW-P | 4,998 | 1.03 | +14.8% | +24.7% | +17.4% |
| DSP Healthcare Fund Dir IDCW-P | 3,514 | 0.51 | +10.1% | +22.8% | +15.5% |
| Mirae Asset Healthcare Dir IDCW-P | 3,253 | 0.44 | +12.5% | +23.7% | +14.6% |
| HDFC Pharma and Healthcare Dir IDCW-P | 2,611 | 1.08 | +19.3% | - | - |
| Tata India Pharma & Healthcare DirIDCW-P | 1,455 | 0.67 | +8.1% | +22.5% | +14.8% |
| UTI Healthcare Dir IDCW-P | 1,308 | 1.31 | +12.7% | +26.4% | +15.4% |
| Aditya BSL Pharma & Hlthcare Dir IDCW-P | 1,011 | 0.82 | +14.5% | +23.1% | +14.0% |
What If I Had Invested?
NAV history not available for this range
Key Metrics
Risk-o-Meter
Low
Moderate
High
Very High
Rated as Very High risk
Disclaimer: Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. NAV data sourced from AMFI. This is not SEBI-registered investment advice.